Wits University announced wednesday that it had suspended the Oxford Covid-19 (OX1nCoc19) vaccine trial in South Africa after a British player experienced what they considered a medical event.
University professor of vaccinology and director of the South African Medical Research Council, Shabir Madhi, who runs the South African trial OX1nCov19, said the popular procedure designed to ensure the protection of participants.
The essay was presented in June when Wits collaborated with the University of Oxford and the Oxford Jenner Institute.
The goal of this trial is to locate a vaccine that will prevent you from infection with SARS-CoV-2, a virus guilty of Covid-19.
Madhi said that after the incident in the UK, the Independent Data and Security Oversight Committee (DSMC) suspended all studies it oversees to allow the committee to adopt a comprehensive review of the UK case.
“Because the South African examination is supervised by the same protection committee, all sites in the country have stopped vaccination. Trial volunteers have been informed that they want to get an immediate first or dose of the vaccine and we touch them to find out when it will be vaccinated. “Resume.
“This resolution will be based on the advice of the DSMC. Ensuring the protection of all participants in our review is our most sensible priority,” Madhi said.
Madhi said that the main points of the medical event that the player experienced in the UK will be revealed as it violates patient confidentiality.
He said the discontinuation of vaccination to review the protective evidence of the application of smart clinical practice and demonstrated the rigor of the independent follow-up procedure under which this trial is conducted.
“The evaluation of the protection of the vaccine is the explanation for why studies like that are in South Africa, before the vaccine is widely used,” Madhi said.
Would you like to comment on this article or see comments from other readers?Sign up (it’s fast and free) or log in now.
Read our comment before commenting.